Ganoderma lucidum polysaccharide peptide alleviates hepatoteatosis via modulating bile acid metaboli

• 作 者: ZHONG Dan-dan YANG Bao-xue
• 机 构: StateKeyLaboratoryofNaturalandBiomimeticDrugs
• 出 处: 中国药理学与毒理学杂志
• 发表日期: 2019年9期
• 关键词: GANODERMA lucidum polysaccharide PEPTIDE NAFLD insulin resistance HEPATOSTEATOSI
• 基金项目: National Natural Science Foundation of China(81330074,81620108029,81261160507),Beijing Natural Science Foundation(7172113).

OBJECTIVE Ganoderma lucidum polysaccharide peptide(GLPP)is a group of extract from Ganoderma lucidum with a molecular mass of approximately 5×10^5,which ratio of polysaccharide to peptide is approximately 95%/5%.The purpose of this study was to deter